ABSTRACT
About Therapeutic Drug Monitoring
Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, demographic, and clinical information. It also considers a posteriori measurement of drug concentration in the blood.
Technavio’s analysts forecast the global therapeutic drug monitoring market to grow at a CAGR of 7.5% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global therapeutic drug monitoring market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Therapeutic Drug Monitoring Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Beckman Coulter
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• Siemens Healthcare
• Thermo Fisher Scientific
Other prominent vendors
• Adaptive Biotechnologies
• AESKU.Diagnostics
• Alere
• bioMérieux
• Bio-Techne
• BÜHLMANN Laboratories
• DiaSorin
• Euro Diagnostica
• Exagen Diagnostics
• IDEXX Laboratories
• InSource Diagnostics
• Merck Millipore
• Miraca Life Sciences
• Myriad Genetics
• Phadia
• Quest Diagnostics
• SEKISUI MEDICAL
• SQI Diagnostics
• Tecan
• Theradiag
Market driver
• Increasing demand for personalized medicine
• For a full, detailed list, view our report
Market challenge
• Shortage of skilled technicians for performing diagnostic techniques
• For a full, detailed list, view our report
Market trend
• Advent of POC tests
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: An overview of therapeutic drug monitoring
PART 06: Market landscape
• Market overview
PART 07: Market segmentation by product type
• Consumables
• Equipment
PART 08: Market segmentation by drug class
• Antiepileptics
• Immunosuppressants
• Antibiotics
• Antiarrhythmics
• Others
PART 09: Market segmentation by end-users
• Hospitals
• Private laboratories
• Others
PART 10: Geographical segmentation
• Therapeutic drug monitoring market in Americas
• Therapeutic drug monitoring market in EMEA
• Therapeutic drug monitoring market in APAC
PART 11: Decision framework
PART 12: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 13: Market trends
• Growing focus toward development of novel therapeutic drug monitoring tools for new indications
• Advent of POC tests
• Advancements in technologies
PART 14: Vendor landscape
• Competitive scenario
PART 15: Key vendor analysis
• Beckman Coulter
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• Siemens Healthcare
• Thermo Fisher Scientific
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global therapeutic drug monitoring market
Exhibit 02: Global therapeutic drug monitoring market 2016-2021 ($ millions)
Exhibit 03: Opportunity analysis in global therapeutic drug monitoring market
Exhibit 04: Five forces analysis
Exhibit 05: Market segmentation by product category 2016
Exhibit 06: Consumables segment in therapeutic drug monitoring market 2016-2021 ($ millions)
Exhibit 07: Equipment segment in therapeutic drug monitoring market 2016-2021 ($ millions)
Exhibit 08: Global therapeutic drug monitoring market segmentation by drug class 2016
Exhibit 09: Global therapeutic drug monitoring market by end-users 2016
Exhibit 10: Segmentation of global therapeutic drug monitoring market based on geography 2016 and 2021
Exhibit 11: Global therapeutic drug monitoring market revenue by geography 2016-2021 ($ millions)
Exhibit 12: Market scenario in Americas
Exhibit 13: Therapeutic drug monitoring market in Americas 2016-2021 ($ millions)
Exhibit 14: Market scenario in EMEA
Exhibit 15: Therapeutic drug monitoring market in EMEA 2016-2021 ($ millions)
Exhibit 16: Market scenario in APAC
Exhibit 17: Therapeutic drug monitoring market in APAC 2016-2021 ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of challenges
Exhibit 20: Competitive structure analysis of global therapeutic drug monitoring market 2016
Exhibit 21: Competitive analysis of global therapeutic drug monitoring market
Exhibit 22: Beckman Coulter: Key highlights
Exhibit 23: Beckman Coulter: Strength assessment
Exhibit 24: Beckman Coulter: Strategy assessment
Exhibit 25: Beckman Coulter: Opportunity assessment
Exhibit 26: Bio-Rad Laboratories: Strength assessment
Exhibit 27: Bio-Rad Laboratories: Strategy assessment
Exhibit 28: Bio-Rad Laboratories: Opportunity assessment
Exhibit 29: F. Hoffmann-La Roche: Key highlights
Exhibit 30: F. Hoffmann-La Roche: Strength assessment
Exhibit 31: F. Hoffmann-La Roche: Strategy assessment
Exhibit 32: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 33: Siemens Healthcare: Strength assessment
Exhibit 34: Siemens Healthcare: Strategy assessment
Exhibit 35: Siemens Healthcare: Opportunity assessment
Exhibit 36: Thermo Fisher Scientific: Key highlights
Exhibit 37: Thermo Fisher Scientific: Strength assessment
Exhibit 38: Thermo Fisher Scientific: Strategy assessment
Exhibit 39: Thermo Fisher Scientific: Opportunity assessment
